Antimicrobial peptides - Advances in development of therapeutic applications
- PMID: 32931796
- PMCID: PMC7486823
- DOI: 10.1016/j.lfs.2020.118407
Antimicrobial peptides - Advances in development of therapeutic applications
Abstract
The severe infection is becoming a significant health problem which threaten the lives of patients and the safety and economy of society. In the way of finding new strategy, antimicrobial peptides (AMPs) - an important part of host defense family, emerged with tremendous potential. Up to date, huge numbers of AMPs has been investigated from both natural and synthetic sources showing not only the ability to kill microbial pathogens but also propose other benefits such as wound healing, anti-tumor, immune modulation. In this review, we describe the involvements of AMPs in biological systems and discuss the opportunity in developing AMPs for clinical applications. In the detail, their properties in antibacterial activity is followed by their application in some infection diseases and cancer. The key discussions are the approaches to improve biological activities of AMPs either by modifying chemical structure or incorporating into delivery systems. The new applications and perspectives for the future of AMPs would open the new era of their development.
Keywords: Anticancer agent; Antimicrobial peptides (AMPs); Antimicrobial resistance; Cosmetic ingredients; Infectious diseases; Medical devices; Peptide drugs.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures






References
-
- Mookherjee N., Anderson M.A., Haagsman H.P., Davidson D.J. Antimicrobial host defence peptides: functions and clinical potential. Nat. Rev. Drug Disc. 2020;19:311–332. - PubMed
-
- Magana M, Pushpanathan M, Santos AL, Leanse L, Fernandez M, Ioannidis A, et al. The value of antimicrobial peptides in the age of resistance. Lancet Infect. Diseas. - PubMed
-
- Alencar-Silva T., Braga M.C., Santana G.O.S., Saldanha-Araujo F., Pogue R., Dias S.C., et al. Breaking the frontiers of cosmetology with antimicrobial peptides. Biotechnol. Adv. 2018;36:2019–2031. - PubMed
-
- da Silva A.M.B., Silva-Gonçalves L.C., Oliveira F.A., Arcisio-Miranda M. Pro-necrotic activity of cationic mastoparan peptides in human glioblastoma multiforme cells via membranolytic action. Mol. Neurobiol. 2018;55:5490–5504. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical